Life Sciences, Diagnostics & Biotechnology Equipment Manufacturing
Strategic Profile
The combination of a differentiated portfolio, the Danaher Business System, and a strong balance sheet positions Danaher for long-term value creation. Growth is supported primarily by consumables tied to commercial biologics production, with approximately three-quarters of bioprocessing revenue linked to commercial manufacturing volumes benefiting from strong monoclonal antibody production.
Cyborg Score Rationale
Underlying biologic demand has grown at double-digit rates annually for over a decade and is expected to continue into 2026, with robust FDA approvals for biologic medicines in 2025 driving global biologic revenues to surpass small molecule drugs for the first time. Danaher appears undervalued with future performance driven by recurring consumables strength, operating leverage, and continued normalization in life sciences demand.
Top Insights
The company expects gradual end market improvements to continue in 2026.
Management guided for 3-6% core revenue growth and adjusted EPS of $8.35-$8.50 in 2026.
Equipment investment has been muted for the last couple of years despite strong consumables demand, suggesting a need for catch-up to meet existing demand.
Stock fell 10% in the last 30 days reflecting valuation compression rather than operational deterioration, with investors focused on conservative 2026 growth guidance despite solid Q4 results.
Named Competitors
Boston Scientific — Medical device manufacturer
Medtronic — Global medical technology company
Fujifilm — Imaging and diagnostics solutions
Recent Developments
(January 2026) Q4 2025 results exceeded expectations with $6.84B revenue and $2.23 adjusted EPS, up 4% YoY
(January 2026) Issued 2026 guidance for 3-6% core revenue growth and $8.35-$8.50 adjusted EPS
(January 2026) Confirmed strong bioprocessing demand and monoclonal antibody production remained robust through Q4
Open the full interactive Danaher Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.